GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $123,479 | -30.6% | 148,270 | 0.0% | 0.00% | – |
Q2 2023 | $177,924 | -32.5% | 148,270 | -29.1% | 0.00% | – |
Q1 2023 | $263,428 | -42.2% | 209,070 | -0.4% | 0.00% | – |
Q4 2022 | $455,635 | -81.9% | 209,970 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $2,515,000 | +503.1% | 209,970 | +321.6% | 0.00% | – |
Q2 2022 | $417,000 | -3.5% | 49,800 | 0.0% | 0.00% | – |
Q1 2022 | $432,000 | -23.1% | 49,800 | +0.2% | 0.00% | – |
Q4 2021 | $562,000 | -10.1% | 49,700 | 0.0% | 0.00% | – |
Q3 2021 | $625,000 | +39.2% | 49,700 | -10.1% | 0.00% | – |
Q2 2021 | $449,000 | -64.5% | 55,300 | -59.5% | 0.00% | -100.0% |
Q1 2021 | $1,264,000 | -9.5% | 136,622 | -5.3% | 0.00% | 0.0% |
Q4 2020 | $1,396,000 | -95.1% | 144,322 | -93.7% | 0.00% | -93.3% |
Q3 2020 | $28,646,000 | -0.2% | 2,308,314 | +4.5% | 0.02% | -11.8% |
Q2 2020 | $28,710,000 | +54.0% | 2,208,430 | +20.3% | 0.02% | +30.8% |
Q1 2020 | $18,639,000 | -31.5% | 1,836,375 | +5.5% | 0.01% | -13.3% |
Q4 2019 | $27,212,000 | -11.5% | 1,741,005 | -4.9% | 0.02% | -21.1% |
Q3 2019 | $30,750,000 | -14.5% | 1,831,446 | +13.0% | 0.02% | -13.6% |
Q2 2019 | $35,961,000 | +19.1% | 1,621,319 | +16.4% | 0.02% | +10.0% |
Q1 2019 | $30,185,000 | – | 1,392,941 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |